66 related articles for article (PubMed ID: 747093)
1. Potential hypolipidemic agents. XVIII. Synthesis and lipid-lowering properties of 2-(dibenzothiophenoxy)-2-methylpropionates and related compounds.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):337-60. PubMed ID: 747093
[No Abstract] [Full Text] [Related]
2. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
Bondesson G; Högberg T; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
[No Abstract] [Full Text] [Related]
3. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
4. Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate.
Gronowitz S; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):361-7. PubMed ID: 747094
[No Abstract] [Full Text] [Related]
5. Potential hypolipidemic agents. XX. Synthesis and lipid-lowering properties of annelated thiophenecarboxylic acids.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):368-81. PubMed ID: 747095
[No Abstract] [Full Text] [Related]
6. Potential hypolipidemic agents. XI. Synthesis, plasma lipid-lowering properties and bioavailability of some esters of 2-(4-dibenzofuranoloxy)-2-methylpropionic acid.
Bondesson G; Högberg T; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(4):361-74. PubMed ID: 1199735
[No Abstract] [Full Text] [Related]
7. Potential hypolipidemic agents. XV Synthesis and plasma lipid-lowering properties of derivatives of 2-phenoxy-2-methylpropionic acid.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(5-6):427-38. PubMed ID: 1020658
[No Abstract] [Full Text] [Related]
8. Potential hypolipidemic agents. XVI. Synthesis and plasma lipid-lowering properties of alpha-substituted ethyl 4-dibenzofuranyloxyacetates and ethyl 4-chlorophenoxyacetates. A comparative study.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1977; 14(2):137-48. PubMed ID: 906831
[No Abstract] [Full Text] [Related]
9. Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1976; 13(1):1-8. PubMed ID: 1258658
[No Abstract] [Full Text] [Related]
10. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH
Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]phenyl]methylene]thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents.
Gupta D; Ghosh NN; Chandra R
Bioorg Med Chem Lett; 2005 Feb; 15(4):1019-22. PubMed ID: 15686904
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.
Kurogi Y; Inoue Y; Tsutsumi K; Nakamura S; Nagao K; Yoshitsugu H; Tsuda Y
J Med Chem; 1996 Mar; 39(7):1433-7. PubMed ID: 8691473
[TBL] [Abstract][Full Text] [Related]
13. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
Lee HW; Kim BY; Ahn JB; Kang SK; Lee JH; Shin JS; Ahn SK; Lee SJ; Yoon SS
Eur J Med Chem; 2005 Sep; 40(9):862-74. PubMed ID: 15908051
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and hypolipidemic activity of novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy) acetic acid derivatives.
Mokale SN; Sanap PT; Shinde DB
Eur J Med Chem; 2010 Jul; 45(7):3096-100. PubMed ID: 20416984
[TBL] [Abstract][Full Text] [Related]
15. (2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agents.
Koyama H; Boueres JK; Miller DJ; Berger JP; MacNaul KL; Wang PR; Ippolito MC; Wright SD; Agrawal AK; Moller DE; Sahoo SP
Bioorg Med Chem Lett; 2005 Jul; 15(14):3347-51. PubMed ID: 15950464
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of N-aryl-1,4-dihydropyridines as novel antidyslipidemic and antioxidant agents.
Kumar A; Maurya RA; Sharma S; Kumar M; Bhatia G
Eur J Med Chem; 2010 Feb; 45(2):501-9. PubMed ID: 19962217
[TBL] [Abstract][Full Text] [Related]
17. Potential hypolipidemic agents. XII. Synthesis and plasma lipid-lowering properties of some 3-pyridylmethyl ethers.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(5-6):445-54. PubMed ID: 1217497
[No Abstract] [Full Text] [Related]
18. Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents.
Chaturvedi D; Ray S; Srivastava AK; Chander R
Bioorg Med Chem; 2008 Mar; 16(5):2489-98. PubMed ID: 18083521
[TBL] [Abstract][Full Text] [Related]
19. Biological evaluation of chalcones and analogues as hypolipidemic agents.
Santos L; Curi Pedrosa R; Correa R; Cechinel Filho V; Nunes RJ; Yunes RA
Arch Pharm (Weinheim); 2006 Oct; 339(10):541-6. PubMed ID: 17009298
[TBL] [Abstract][Full Text] [Related]
20. Novel euglycemic and hypolipidemic agents. 1.
Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
